Yufeng Xu

3.5k citations
60 papers · 2.3k indexed · 1 hit paper · h-index 23
Topics
Retinal Diseases and Treatments (14 papers)Retinal Imaging and Analysis (14 papers)Mitochondrial Function and Pathology (7 papers)

In The Last Decade

Yufeng Xu

58 papers receiving 2.3k citations

Hit Papers

Global, regional, and national burden and trend of diabet...202020262022202420204008001.2k

Peers

Yufeng Xu
Comparison fields: 5 of 161
  • Endocrinology, Diabetes and Metabolism 531
  • Molecular Biology 504
  • Ophthalmology 362
  • Epidemiology 340
  • Radiology, Nuclear Medicine and Imaging 289
Replace Xiang Li with:
Xiang Li China
Kyung Soo Ko South Korea
Lei Liu China
Carolyn Robinson United States
Lijuan Wu China
Chee Fang Sum Singapore
Xue Sun China
W. Todd Cade United States
Halla Mustafa United Arab Emirates
C Ionescu-Tîrgovişte Romania
Yufeng Xu relative to Xiang Li China Xiang Li's profile →
Citations per field
00.5×2.5×
Xiang Li · 1×
Citations per year

Countries citing papers authored by Yufeng Xu

Since Specialization
Citations

This map shows the geographic impact of Yufeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Xu more than expected).

Fields of papers citing papers by Yufeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Xu. The network helps show where Yufeng Xu may publish in the future.

Co-authorship network of co-authors of Yufeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Xu. A scholar is included among the top collaborators of Yufeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Xu. Yufeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 38
4 22
5 30
6 14
7 56
8 8
9 55
10 17
11 12
12 13
13 31
14 4
15 5
16 48
17 37
18 11
19 30
20 10

About Yufeng Xu

Yufeng Xu is a scholar working on Ophthalmology, Clinical Biochemistry and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 2.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (14 papers), Retinal Imaging and Analysis (14 papers) and Mitochondrial Function and Pathology (7 papers). The work is most often cited by research in Ophthalmology (362 citations), Endocrinology, Diabetes and Metabolism (531 citations) and Clinical Biochemistry (102 citations). Yufeng Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiling Lin, Xiaowen Pan, Jingya Xu, Yuezhong Ren, Xue Sun, Yue Ding, Xiaoxiao Song, Lixia Lou, Juan Ye and Kai Jin. Their work appears in journals such as Cell, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026